Anandani Nellan, MD, MPH
Instructor, Pediatrics-Heme/Onc and Bone Marrow Transplantation


  • Nellan A, McCully CML, Cruz Garcia R, Jayaprakash N, Widemann BC, Lee DW, Warren KE. Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques. Blood. 2018 Aug 9;132(6):662-666. PubMed PMID: 29954750
  • Nellan A, Rota C, Majzner R, Lester-McCully CM, Griesinger AM, Mulcahy Levy JM, Foreman NK, Warren KE, Lee DW. Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells. J Immunother Cancer. 2018 Apr 30;6(1):30. PubMed PMID: 29712574
  • Witt DA, Donson AM, Amani V, Moreira DC, Sanford B, Hoffman LM, Handler MH, Levy JMM, Jones KL, Nellan A, Foreman NK, Griesinger AM. Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy. Pediatr Blood Cancer. 2018 Jan 19. [Epub ahead of print] PubMed PMID: 29350470

Practice Locations

Children's Hospital Colorado
13123 East 16th Ave
Aurora, CO 80045

Specialty Information

  • Pediatric Hematology / Oncology, Board Certification
Clinical Interests
I moved to Colorado for a clinical fellowship in Neuro-oncology after completing my training in Pediatric Hematology and Oncology at the combined training program at Johns Hopkins University/National Cancer Institute. I joined the faculty here as a clinician and researcher. I care for children and young adults with brain and spine tumors.

Care Philosophy
The physical and psychological impact of tumors on a patient can vary greatly based on age, tumor type and necessary treatment. I hope to offer patients and their families the most current therapeutic options, working alongside an excellent multi-disciplinary team here at Children's Hospital Colorado.

Personal Interests
Yoga, travel, reading, and spending time with my family.

General Information

Department: Pediatrics-Heme/Onc and Bone Marrow Transplantation